Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11566-11573

  Wang, X ^a   Li, M ^a   Zheng, H ^a   Muster, T ^a   Palese, P ^a   Beg, A A ^a   Garcia Sastre A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN NS1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; INFLUENZA A VIRUS; INTERFERON-ALPHA; INTERFERON-BETA; MICE; NF-KAPPA B; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0034466776     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11566-11573.2000     Document Type: Article

References (66)

1. IκB-mediated inhibition of virus-induced beta interferon transcription
2. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus
3. The Ebola virus VP35 protein functions as a type I interferon antagonist
4. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
5. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex
6. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation
7. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
8. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery
9. JNK2 and IKKβ are required for activating the innate response to viral infection
10. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs
11. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation
12. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
13. Influenza virus NS1 protein stimulates translation of the M1 protein
14. Characterization of influenza virus NS1 protein by using a novel helper-virus-free reverse genetic system
15. High-efficiency formation of influenza virus transfectants
16. Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase
17. Rescue of influenza A virus from recombinant DNA
18. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport
19. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB
20. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
21. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action
22. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state
23. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
24. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses
25. High virulence of attenuated Rift valley fever virus in mice lacking a functional type I interferon system
26. Binding of influenza A virus NS1 protein to dsRNA in vitro
27. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells
28. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-κB site of the human immunodeficiency virus enhancer
29. Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression
30. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive factors
31. Phosphorylation meets ubiquitination: The control of NF-κB activity
32. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome
33. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
34. Unique functions of the NS1 protein
35. The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction
36. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein
37. The influenza virus NS1 protein: A novel inhibitor of pre-mRNA splicing
38. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor
39. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
40. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo
41. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription
42. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs
43. Activation of multiple growth regulatory, genes following inducible expression of IRF-1 or IRF/RelA fusion proteins
44. Efficient selection for high-expression transfectants with a novel eukaryotic vector
45. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins
46. Expression of a foreign protein by influenza A virus
47. Identification and characterization of an IκB kinase
48. Regulation of type I interferon gene expression by interferon regulatory factor-3
49. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule
50. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response
51. Interferon-induced antiviral actions and their regulation
52. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes
53. Regulation of influenza virus RNA polymerase activity by cellular and viral factors
54. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
55. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
56. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase
57. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids
58. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo
59. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1
60. The Bunyamwera virus nonstructural protein NSs is a repressor of the viral polymerase and confers interferon antagonistic function
61. PKR: A sentinel kinase for cellular stress
62. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
63. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/ p300
64. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response
65. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase
66. A cell type-specific enhancer in the human B7.1 gene regulated by NF-κB